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A cryptosporidiosis survey showed the presence of 
Cryptosporidium hominis, C. parvum, C. canis, and C. felis 
in 25, 7, 1, and 1 HIV-positive persons from Jamaica, respec-
tively; 1 person had both C. hominis and C. felis. Multilocus 
sequence typing indicated the presence of a homogeneous 
but geographically distinct C. hominis population in Jamaica.
C
ryptosporidiosis is endemic to most tropical countries 
including Jamaica (1). Some evidence suggests that 
clinical manifestations of cryptosporidiosis may vary ac-
cording to Cryptosporidium species and subtypes (2,3). 
Differentiating the species and subtypes with an aim of un-
derstanding the transmission dynamics of the parasites in 
disease-endemic areas requires the use of high resolution 
molecular tools (4). So far, few studies have reported on the 
molecular epidemiology of cryptosporidiosis in the Carib-
bean region, and only 2 small-scale studies on Cryptospo-
ridium spp. in HIV-infected persons in Haiti have been 
conducted (5,6). In this preliminary study, genotyping and 
multilocus sequence typing (MLST) techniques were used 
to investigate the transmission of cryptosporidiosis among 
HIV-infected patients in Jamaica.
The Study
Stool specimens were obtained from HIV-infected 
adults in Kingston, Jamaica, as part of routine parasitologic 
diagnosis. All patient identiﬁ  ers were removed before spec-
imen acquisition. A total of 35 Cryptosporidium-positive 
stool specimens were collected from May 2003 through 
July 2007. Only 1 specimen per patient was included in the 
study. Specimens were collected from multiple hospitals 
in Kingston; some of the patients were from outlying areas 
who came to Kingston for medical care. Specimens were 
stored in 2.5% potassium dichromate at 4°C before analy-
sis. Thereafter, DNA was extracted by using the FastDNA 
Spin Kit for Soil (Qbiogene Inc., Carlsbad, CA, USA); 
Cryptosporidium spp. were identiﬁ  ed on the basis of PCR–
restriction fragment length polymorphism analysis of the 
small subunit ribosomal RNA gene as described (7). Iden-
tiﬁ  cation of C. hominis and C. parvum subtypes was based 
on sequence polymorphism at the 60-kDa glycoprotein 
gene (GP60) locus by using the nomenclature described 
(8). Nineteen of the 25 C. hominis–positive specimens 
and all 7 C. parvum–positive specimens were analyzed 
by MLST. The typing targeted 5 additional loci, including 
the 47-kDa protein (CP47 microsatellite), a serine repeat 
antigen (MSC6–7 minisatellite), a hypothetical retinitis 
pigmentosa GTPase regulator (RPGR minisatellite), and 
a hydroxyproline-rich glycoprotein (DZHRGP minisatel-
lite and microsatellite) in chromosome 6 and the 70-kDa 
heat shock protein (HSP70 minisatellite) in chromosome 2. 
Nomenclature and classiﬁ  cation of subtypes at these 5 loci 
have been described (9).
Genotype analysis of the 35 Cryptosporidium–posi-
tive specimens showed that 25 had C. hominis, 7 had C. 
parvum, 1 had C. canis, 1 had C. felis, and 1 had both C. 
hominis and C. felis. Initial subtyping of C. hominis and 
C. parvum used sequence analysis of the GP60 gene. Most 
(22) C. hominis specimens had subtype IbA10G2; 3 had 
subtype IeA12G3T3. All 7 C. parvum specimens belonged 
to subtype IIcA5G3d, which was identical to C. parvum 
identiﬁ  ed in children in South Africa (GenBank accession 
no. AF440636).
Results of the MLST analysis of the additional 5 loci 
showed limited gene diversity in C. hominis. At the CP47 
locus, all 19 specimens analyzed belonged to subtype 
IA39G22. Most of the other loci were also monomorphic, 
and subtypes at these loci were identiﬁ  ed by amplicon siz-
es. All specimens were 590 bp at the DZHRGP locus, 358 
bp at the RPGR locus, and 1,095 bp at the HSP70 locus. 
At the MSC6–7 locus, 18 of the 19 C. hominis specimens 
analyzed were 494 bp; 1 was 509 bp.
Diversity was more pronounced in the MLST analy-
sis of C. parvum, although all specimens belonged to 
IIcA5G3d subtype at the GP60 locus. There were 3 sub-
types at the DZHRGP locus. Subtype 1 was 496 bp and 
was found in 4 specimens. Subtype 2 was also 496 bp but 
had 1 single nucleotide polymorphism at position 314; this 
subtype was seen in 2 specimens. Subtype 3 was 499 bp 
and was found in 1 specimen. The HSP70 locus had 2 sub-
types, differentiated by the presence of a single nucleotide 
polymorphism (a change of C to T at position 172), with 6 
of the 7 specimens in 1 subtype. All C. parvum specimens 
were monomorphic at the CP47, MSC6–7, and RPGR loci. 
Results of the C. hominis and C. parvum subtyping at the 5 
loci are shown in the Table.
To measure the degree of heterogeneity of C. homi-
nis and C. parvum, an MLST analysis was conducted to 
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geographic areas of similar GP60 subtype families Ib, Ie 
and IIc (Kenya, Peru, India, and USA). All sequences for 
each specimen at the 5 loci were concatenated and multilo-
cus subtypes generated. The analysis showed C. hominis 
multilocus subtypes from Jamaica clustered in 1 group, 
regardless of their GP60 subtype designation. Specimens 
of the same GP60 subtypes from other regions clustered 
in clades separate from the Jamaica specimens, forming 
largely distinct monophyletic groups deﬁ  ned by geograph-
ic origin. Specimens from Kenya and India clustered in 1 
clade because of extensive human migration between the 2 
countries. Although all C. parvum specimens from Jamaica 
were identiﬁ  ed as IIcA5G3d, 4 MLST types were present, 
highlighting the extent of genetic diversity of C. parvum 
in this study. The relationship of the multilocus subtypes 
based on the 5 loci inferred by neighbor-joining analysis is 
shown in the Figure.
Conclusions
Results of our study show that anthroponotic transmis-
sion is important in the epidemiology of cryptosporidiosis 
in Jamaica. This conclusion is based on our ﬁ  nding of C. 
hominis and anthroponotic C. parvum (the IIc subtype fam-
ily) in 33 (94%) of 35 specimens analyzed. Because all C. 
parvum–positive specimens belonged to the anthroponotic 
subtype family IIc and because 1 of the C. felis–infected 
patients had concurrent infection with C. hominis, it is pos-
sible that some of the C. canis and C. felis infections seen 
in this study were transmitted through anthroponotic path-
ways. 
Results of the GP60 subtyping showed only 2 C. 
hominis subtype families (Ib and Ie); most belonged to the 
IbA10G2 subtype. Although the sample size is small, ho-
mogeneity within C. hominis at the GP60 locus is unusual, 
as common subtype families such as Ia and Id are usually 
equally abundant in most developing countries (2,10,11). 
Only some industrialized nations, such as Portugal and the 
United Kingdom, are known to have limited heterogeneity 
in C. hominis infections in humans (12,13). The GP60 sub-
type IbA10G2 identiﬁ  ed here is identical to that previously 
reported in the United States, the United Kingdom, Portugal, 
South Africa, and Peru. Another Ib subtype, IbA9G3, which 
was commonly reported in India, Malawi, and Australia 
(4,8,10–12), was not seen in the specimens from Jamai-
ca. Likewise, most Ie infections in humans are caused by 
IeA11G3T3, but our study identiﬁ  ed a less common sub-
type, IeA12G3T3, which was also found in specimens from 
New Orleans (USA) and Australia (4). The limited num-
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Table. Subtypes of Cryptosporidium hominis and C. parvum at 6 loci identified in specimens from Jamaica* 
GP60 CP47 MSC6-7 DZHR-GP RPGR HSP70
Cryptosporidium hominis, n = 25 (19 used in MLST) 
IbA10G2 (22)  494 bp (18)  590 bp (19)  358 bp (19)  1095 bp (19) 
IeA12G3T3 (3) 
IA39G22 (19) 
509 bp (1) 
C. parvum, n = 7 (7 used in MLST) 
IIA24G11C1 (7)  461 (7)  496a bp (4)  391 bp (7)  1059a bp (6) 
496b bp (2)  1059b bp (1) 
IIcA5G3d (7) 
499 bp (1) 
*Numbers in parentheses show the frequency of subtypes at each locus. MLST, multilocus sequence typing. 
Figure. Relationships among  Cryptosporidium hominis and C. 
parvum multilocus sequence subtypes at 5 genetic loci. Parasite 
population from Jamaica was compared with that from other regions 
by neighbor-joining analysis of concatenated sequence of 5 genetic 
loci, by using GP60 subtype identiﬁ  cation in specimen selection. The 
Kimura 2-parameter model was used in the distance calculations. 
The sequences reported in this paper are available in the GenBank 
database under accession nos. EU141710–EU141727.Cryptosporidium Population in HIV-Infected Jamaicans
ber of GP60 subtypes would suggest an epidemic mode of 
transmission. The extended period of specimen collections 
and the identiﬁ  cation of other Cryptosporidium species do 
not indicate that a cryptosporidiosis outbreak occurred dur-
ing this long study period.
All C. hominis specimens from Jamaica, irrespective 
of the GP60 subtype (IbA10G2 or IeA12G3T3), belonged 
mostly to 1 MLST group distinct from other subtypes 
from other geographic regions. These results suggest that 
a unique C. hominis parasite population is being transmit-
ted in Jamaica. Heterogeneity was higher in the C. parvum 
population despite the smaller number of specimens that 
we analyzed. As with C. hominis, a unique population of C. 
parvum in Jamaica also seems to exist. These results fur-
ther show the distinct population of Cryptosporidium spp. 
that can arise because of geographic segregation. When one 
considers that all C. parvum specimens belonged to only 
1 GP60 subtype, whether the high diversity seen with the 
MLST is due to recent expansion of an ancestral type in 
the region is not clear. A study of population genetics of 
Cryptosporidium spp. from humans in Haiti showed lim-
ited multilocus subtypes in both C. hominis and C. parvum, 
which was interpreted as an indication for an epidemic 
clonal population for both species (6).
The occurrence of unique multilocus subtypes in both 
C. hominis and C. parvum populations in Jamaica that can 
be differentiated from other geographic regions, including 
the nearby United States, is notable and requires further 
investigations. The distinction is important in mapping 
the transmission of the parasite, especially where track-
ing infection pathways is necessary, such as in investiga-
tions of outbreaks and traveler’s diarrhea. The fact that C. 
hominis from different areas may have an identical GP60 
subtype but a different MLST subtype is also noteworthy, 
as some C. hominis subtypes, such as IbA10G2, are com-
monly associated with water-borne outbreaks in industri-
alized countries. The clinical manifestations of the GP60 
subtypes in relation to the distinct MLST from different 
geographic areas needs to be studied further. This would 
clarify how geographic segregation in Cryptosporidium 
MLST subtypes relates to GP60 subtypes that have various 
pathogenicities.
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